https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Fri, 28 Jan 2022 09:23:17 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/y2biheenxq-exciting-advances-in-car-t-and-tcr-research/ Tue, 24 Aug 2021 13:22:11 +0000 http://13.40.107.223/video/y2biheenxq-exciting-advances-in-car-t-and-tcr-research/ David Gilham, PhD, Celyad Oncology, Mont-Saint-Guibert, Belgium, offers some of his highlights from the CAR-TCR Summit Europe 2021. He describes CYAD-211, a short hairpin RNA (shRNA)-based B-cell maturation antigen (BCMA)-targeting allogeneic chimeric antigen receptor (CAR) T candidate, which is being investigated in ongoing clinical trials for the treatment of patients with relapsed or refractory multiple myeloma (r/r MM). He also discusses exciting developments presented at the meeting, included advances in the understanding of the mechanisms of action of CD19-targeting CAR T-cell therapies, as well as advances in T-cell receptor (TCR) platforms under investigation. This interview took place during the CAR-TCR Summit Europe 2021.

]]>